Dermocosmètica
Dermocosmètica is a privately held Australian specialty distributor (founded 2011, 11–50 employees) that supplies premium, science-backed dermocosmetic products — cosmeceuticals, peels, therapeutic skincare, and injectables — from 11 global brands to more than 1,500 medical, aesthetic, and pharmacy stockists across Australia and New Zealand.
- Company typePrivate
- Founded2011
- HeadquartersCoburg, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dermocosmètica does
Dermocosmètica Pty Ltd is an Australian specialty distributor that supplies premium, science-backed dermocosmetic products — cosmeceuticals, medical-grade peels, therapeutic skincare, and injectables — to medical and aesthetic clinics across Australia and New Zealand. The company is the exclusive regional distributor for at least eleven global brands, including IBSA Derma (Profhilo, Viscoderm), Biopelle (Tensage, Emepelle), Cantabria Labs (Biretix, Neoretin), Dermaceutic Laboratoire, Isdinceutics, Eneomey, Prescribed Solutions DNA, OC Eight, and LMX4. These brands carry clinically validated, often patented proprietary technologies such as NAHYCO (hybrid hyaluronic acid), SCA Biorepair (snail secretion), MEP (menopause skin), RetinSphere, BIOPEP-15, and ACRYSORB. Dermocosmètica wraps distribution in a clinical-education ecosystem — the Skin Health & Beauty Pyramid, IBSA Master Injector Academy, KOL-led workshops, and conference sponsorships (ASCD, COSMETEX, ADNA, ASAPS) — and supports more than 1,500 stockists via five regional Business Development Managers covering VIC, NSW/ACT, QLD/NT, WA/SA, and New Zealand.
Revenue is generated through wholesale distribution to authorised medical and aesthetic clinics, not direct-to-consumer sales. The company does not publish pricing and operates without a public online store; select consumer products (e.g., LMX4) reach consumers via pharmacy chains such as Terry White Chemists and Pharma Save. Founded in 2011 and headquartered in Coburg North, Victoria, Dermocosmètica is a privately held, founder/management-controlled Australian company with no disclosed institutional investors, no public listing, and a headcount of 11–50. The business holds a strong regional distribution position — Australia is IBSA's largest global market and was ranked second globally for Emepelle sales by 2021 — and continues to add brands and education infrastructure, most recently launching Eneomey (April–May 2025) and a new IBSA product across Australia in April 2025, alongside the appointment of Dr David Kosenko (CPCA President) as Head of Medical & Clinical Training.
Dermocosmètica firmographics
Firmographics- Name
- Dermocosmètica
- Legal name
- Dermocosmética Pty Limited
- Website
- https://dermocosmetica.com.au
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dermocosmètica is a privately held Australian specialty distributor (founded 2011, 11–50 employees) that supplies premium, science-backed dermocosmetic products — cosmeceuticals, peels, therapeutic skincare, and injectables — from 11 global brands to more than 1,500 medical, aesthetic, and pharmacy stockists across Australia and New Zealand.
- Ownership category
- akta.pro rank
Dermocosmètica industry classification
Industry- Product category
- Medical-grade dermocosmetic distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
Keywords
Where Dermocosmètica is headquartered
LocationHeadquarters
- HQ city
- Coburg
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Dermocosmètica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Others
Revenue model
- Wholesale / B2B Distribution: Dermocosmètica generates revenue by distributing premium dermocosmétic products (cosmeceuticals, professional peels, therapeutic skincare, injectables) to authorised medical clinic stockists across Australia and New Zealand. The company does not sell direct to the public. Revenue is derived from wholesale orders placed by clinics, with the company managing logistics through a 3PL freight partner.
Go-to-market motion4 records
Distribution channels3 records
Marketing channels10 records
Dermocosmètica product offering
Product offeringCore offering
Dermocosmètica distributes premium, science-backed dermocosmetic products — including cosmeceuticals, professional peels, therapeutic skincare, and injectables — from 11 global brand partners (Dermaceutic, Biopelle, Isdinceutics, Emepelle, Cantabria Labs' Biretix and Neoretin, IBSA Derma, Eneomey, Prescribed Solutions DNA, OC Eight, and LMX4) exclusively to authorised medical clinics, pharmacies, and hospitals across Australia and New Zealand. The company does not sell direct to consumers; revenue is generated through wholesale orders placed by over 1,500 stockists, supported by territory-based Business Development Managers, clinical training programs, and KOL-led education.
Product overview
Dermocosmètica is a distributor of premium dermocosmetic products to medical clinics across Australia and New Zealand, not a software platform. The company offers a portfolio of 11 major brands: Dermaceutic Laboratoire (cosmeceuticals and professional peels), Biopelle (Tensage Growth Factors and Stem Cell products with SCA Biorepair Technology), Isdinceutics (high-potency active ingredient skincare), Emepelle (MEP Technology for menopausal skin), LMX4 (topical anesthetic), Prescribed Solutions DNA (DNA repair enzymes), Cantabria Labs brands including Biretix (retinoid acne treatment) and Neoretin (pigmentation correction), IBSA Derma (Profhilo hyaluronic acid products using NAHYCO Technology, Viscoderm skincare), Eneomey (French professional peels and skincare), and OC Eight (oil control). Products are sold exclusively through over 1,500 medical clinic stockists, not direct-to-consumer online.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermaceutic Laboratoire A leading global cosmeceutical brand offering professional peels and homecare skincare products backed by science. Includes professional treatments (Milk Peel, Mela Peel Forte, Cosmo Peel 12%) and homecare products (Mela Cream, Hyal Ceutic, Hyal Ceutic Redens+, Regen Ceutic, C25 Cream, Tri Vita C30, Advanced Cleanser, Foamer 5/15, Actibiome, Oxybiome). Distributed to medical clinics across Australia and New Zealand.
- Biopelle Advanced skincare brand featuring Tensage Growth Factors and Tensage Stem Cell products using SCA Biorepair Technology derived from Cryptomphalus Aspersa snail secretion. Includes Retriderm, Brighten, and Exfoliate product lines. Distributed to Australian clinics since 2013; Australia ranked second globally for Emepelle sales by 2021.
- Isdinceutics Brand from ISDIN (Spain's No. 1 skincare brand since 1975) offering cosmeceuticals with high concentrations of active ingredients including melatonin and ultraglycans. Hero products include Retinal Intense, Melaclear Advanced, Hyaluronic Concentrate, and K-Ox Eyes. Categories span Cleanse, Rejuvenate, Prevent, Brighten, Renew, and Specific Care.
- Emepelle First and only skincare range with MEP Technology (Methyl Estradiolpropanoate), a non-hormonal estrogen receptor activator specifically engineered to address menopausal estrogen-deficient skin. Clinically proven to decrease wrinkles, improve texture and color, and facilitate better skin hydration. Australia ranked second globally for Emepelle sales by 2021.
- LMX4 Topical anaesthetic product available through Terry White Chemists, Pharma Save, and other leading pharmacy stores as well as medical clinics. Provides consumer-accessible anaesthetic outside the clinic channel.
- Prescribed Solutions DNA DNA repair skincare using encapsulated DNA repair enzymes (Photosomes, Roxisomes, Ultrasomes) delivered in liposomal systems to reverse UV and pollution-induced DNA damage and protect against future damage.
- Biretix Expert retinoid brand for acne-prone skin using RetinSphere Technology (hydroxypinacolone retinoate and stabilised encapsulated retinol) and BIOPEP-15 botanical polypeptide complex. Clinically proven to fight Cutibacterium acnes (24 strains) and reduce acne in as little as 8 weeks.
- Neoretin Epidermal renewal and skin lightening range using RetinSphere Technology and Edafence for maximum protection against pollution. Targets pre-existing pigmentation and prevents new pigment formation; 75% of Asian patients showed improvement in spots and hyperpigmentation in 30 days.
- IBSA Derma Global aesthetics and dermatology brand leveraging IBSA Group's pharmaceutical heritage (Switzerland, established 1945). Products include Profhilo injectables, Profhilo Haenkenium, Profhilo Figura, Profhilo Pura, and Viscoderm skincare. Uses patented NAHYCO Technology combining high- and low-molecular-weight hyaluronic acid without chemical cross-linking agents.
- Eneomey French dermo-cosmetic brand founded by Audrey Talayrach, distributed in 18 countries. Offers professional peels (Purify Peel, Lumilight Peel, Rejuv Peel) and comprehensive skincare programs including cleansers, Daylight C20, Rejuv Elixium, Rejuv Silk, Stim Renew, Hyaluronic Masque, Perfect Body, and lip products. All products cruelty-free and allergen-free.
- OC Eight First medical solution for controlling facial shine using ACRYSORB copolymer micro-particle technology. Traps up to 6 times its own volume in oil for up to 8 hours without chemical absorption. Ideal as makeup primer and suitable for all skin types including acne-prone and sensitive skin.
- Hyal Ceutic Redens+ Rich redensifying cream for very mature skin using polyglutamic acid, three-molecular-weight hyaluronic acid, ceramides, and L-MTX. Targets the SENEB zone to visibly redefine facial contours and improve skin density and firmness (+10% firmness, +7% skin density in 56 days).
- Mela Cream Pigmentation cream containing nine proven pigment-reducing ingredients including niacinamide, retinol, salicylic and mandelic acids, phytic acid, licorice extract, and kojic acid. Clinically proven to reduce appearance of pigment spots, melasma, and post-inflammatory hyperpigmentation.
- OC Eight Mattifying Gel Clinically proven mattifying gel using ACRYSORB micro-particles that trap facial oils for up to 8 hours. Reduces shine and redness without drying skin; ideal as makeup primer for even-toned, matte skin.
- Rejuv Peel Superficial dermatological peel for age-defying treatment using glycolic acid, retinol, and ferulic acid. Stimulates epidermis renewal, improves skin texture, radiance, firmness, and elasticity.
- Lumilight Peel Superficial dermatological peel for radiance boosting using phytic acid and mandelic acid. Speeds up epidermis renewal to even out pigmentation and reduce pigment defects.
- Purify Peel Superficial dermatological peel using salicylic acid for purifying treatment. Reduces buildup of dead skin cells, refines skin texture, decreases pore size, and reduces oil on skin. Indicated for oily, acne-prone skin with dilated pores.
- Viscoderm Hydrogel Patch Post-treatment hydrating and soothing hydrogel mask with gradual release of hyaluronic acid, bisabolol, and aloe vera. Soothes, refreshes, and moisturizes face, neck, and décolletage through osmosis technology.
- Viscoderm Hydrobooster Cream Moisturizing barrier cream containing high-molecular-weight hyaluronic acid, jojoba oil, and shea butter. Restores hydrolipidic film and provides intense hydration and skin barrier restoration post-treatment.
- Profhilo Pura Gentle multipurpose cleanser with hyaluronic acid and micellar solution that removes makeup and dirt without stressing skin barrier. Contains alpha-glucan oligosaccharide for microbiota health.
- Profhilo Figura Body cream with high and low molecular weight hyaluronic acid and Matrixyl 3000 peptides. Indicated for toning skin that has lost elasticity and hydration. Clinically proven to improve skin moisturization by 42.4% and elasticity by 6.3% in 28 days.
- Profhilo Haenkenium Multi-action antioxidant cream combining patented hyaluronic acid complex with Salvia Haenkei extract (HAENKENIUM). Provides immediate hydration, natural antioxidant protection, and long-term skin rejuvenation. Clinical studies show 30% reduction in wrinkle depth and 90% improvement in skin elasticity in 12 weeks.
Quantifiable outcome
- 30% reduction of wrinkles depth (Profhilo Haenkenium, 100 patients, 12 weeks)
- +10 more outcomes
Companies that use Dermocosmètica
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Dermocosmètica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Dermocosmètica partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core, secondary and minor.
- Eneomey (Laboratoire ENEOMEY)coreEneomey is a French dermo-cosmetic brand founded by Audrey Talayrach (over 30 years experience with dermatologists, surgeons, and aesthetic physicians), based in Cagnes-sur-Mer, France. Distributed in 18 countries. Products include professional peels (Rejuv Peel, Lumilight Peel, Purify Peel) and homecare (Daylight C20, Rejuv Silk, Hyaluronic Masque, Lip products, Perfect Body). Launched in Australia through Dermocosmètica in April/May 2025 with events in Brisbane, Sydney, and Melbourne.
- Leo Magnani and Derris Loy (IBSA HQ, Italy)coreLeo Magnani and Derris Loy from IBSA Headquarters in Italy joined Dermocosmética's sold-out Australian product launch events as expert speakers, presenting the science, innovation, and clinical results behind IBSA products. Derris Loy noted Australia as IBSA's biggest market globally.
- Audrey Talayrach (Eneomey Founder)coreAudrey Talayrach, Founder and Managing Director of Laboratoire ENEOMEY, personally attended Australian launch events in Brisbane, Sydney, and Melbourne (April-May 2025), sharing her 30+ years of skincare expertise and brand philosophy directly with Australian clinicians and Dermocosmética team.
- Eric Fleming (Biopelle / Sommar Bio)coreEric Fleming from Biopelle/Sommar Bio (Michigan, USA) attended Dermocosmética's 10-year Biopelle anniversary celebrations in Australia, reinforcing the global partnership between the two companies.
- EmepellecoreEmepelle launched in Australia in 2019 through Dermocosmètica as the first and only skincare range to treat the root cause of menopausal skin ageing using MEP Technology. By 2021, Australia ranked second globally for Emepelle sales, second only to the US.
- Biopelle (Sommar Bio, Inc.)coreDermocosmètica has distributed Biopelle products in Australia since 2013, celebrating 10 years of partnership in 2023. Biopelle is a leader in advanced skincare solutions with award-winning, cutting-edge technologies including SCA Biorepair Technology. Sub-brands include Tensage Growth Factors, Tensage Stem Cell, Retriderm, Brighten, and Exfoliate. By 2021, Australian clinics ranked second globally for Emepelle sales.
- Dermaceutic LaboratoirecoreDermocosmètica distributes Dermaceutic Laboratoire products across Australia and New Zealand. Dermaceutic is a leading global cosmeceutical brand founded on the belief that science is the skin's natural ally, offering professional peels and homecare cosmeceuticals.
- ISDIN / ISDINCEUTICScoreDermocosmètica distributes ISDINCEUTICS products — Spain's No. 1 brand founded in 1975, headquartered in Barcelona. ISDIN is present in 56 countries with 14 subsidiaries and 43 export partners. The brand is B-Corp certified and known for photoprotection expertise, ultraglycans, and innovative ingredients including melatonin. Hero products include Retinal Intense, Melaclear Advanced, Hyaluronic Concentrate, and K-Ox Eyes.
- Terry White Chemists / Pharma SavesecondaryLMX4 is distributed through Terry White Chemists, Pharma Save and other leading pharmacy stores, providing consumer access to this specific product line outside the clinic channel.
- PRESCRIBEDsolutions / DNAsecondaryDermocosmètica distributes PRESCRIBEDsolutions DNA repair skincare, which uses a combination of DNA repair enzymes (Photosomes, Roxisomes, Ultrasomes) in liposomal delivery systems for comprehensive DNA repair.
- Cantabria Labs (Biretix & Neoretin)coreDermocosmètica distributes Cantabria Labs products including Biretix (expert retinoid brand for acne-prone skin using RetinSphere Technology and BIOPEP-15) and Neoretin (pigment-correcting range using RetinSphere and Edafence). Cantabria Labs is leader in dermatological prescription in Spain, Italy and Portugal, with over 840 employees and manufacturing over 30 million units annually.
- IBSA DermacoreDermocosmètica distributes IBSA Derma products including Profhilo (Haenkenium, Figura, Pura), Viscoderm Hydrobooster Cream, Viscoderm Hydrogel Patch, Viscoderm Cover Up, and Profhilo Structura. IBSA is headquartered in Switzerland (1945), operates in 80+ countries, with all production in Italy. Uses patented NAHYCO Technology for hybrid hyaluronic acid complexes. Australia is IBSA's biggest market globally.
- OC Eight (Revance)secondaryDermocosmètica distributes OC Eight Professional Mattifying Gel, the first medical solution for controlling facial shine for up to 8 hours using ACRYSORB copolymer technology. OC Eight is dermatologist tested and approved by leading make-up artists.
- Local Freight Solutions Pty LtdminorMelbourne-based third-party logistics (3PL) freight partner managing distribution of all Dermocosmética products. Appointed to handle warehousing and delivery operations.
- Dr David KosenkocoreDr David Kosenko serves as Dermocosmética's Head of Medical & Clinical Training. He is the current President of the Cosmetic Physicians College of Australasia (CPCA), graduated Monash University 1987, and earned Fellowship with RACGP in 1994. He leads clinical education expansion and training programs for aesthetic professionals.
- Dr Eyal KramercoreDr Eyal Kramer is a key opinion leader for Dermocosmética, featuring in hands-on injectable workshops at the 2025 ASCD Symposium and podcast appearances. Expert in advanced injectable techniques and treatment planning.
- Dr Cara McDonaldcoreDr Cara McDonald is a key opinion leader for Dermocosmética, presenting at IBSA product launch events and ASCD 2025 Symposium workshops. Expert in clinical applications of IBSA products.
- Dr Ellen SelkoncoreDr Ellen Selkon is a key opinion leader for Dermocosmética, presenting at IBSA PR events and product launches, sharing expert insights on clinical applications of IBSA aesthetic products.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Dermocosmètica competitors and assessment
Company assessmentBroad incumbents
- AbbVie (Allergan Aesthetics): Global aesthetics powerhouse (Botox, Juvederm, SkinMedica, CoolSculpting). Competes in the same clinic channel for injectable and skincare budgets but as a manufacturer with direct sales infrastructure.
- Sinclair Pharma: Global aesthetics company (maili, Perfectha, Lanluma) selling into medical aesthetic clinics. Comparable end customer (appearance medicine practitioners) and product category (dermal fillers, bio-remodelling).
- Galderma: Global dermatology-focused pharmaceutical company (Cetaphil, Restylane, Sculptra) with a direct ANZ presence. Overlaps significantly in dermatology/skincare but as a vertically integrated manufacturer, not a pure distributor.
- Croma-Pharma: Austrian manufacturer of hyaluronic acid-based aesthetics (Princess, saypha) and professional skincare. Overlaps in aesthetic injectables distributed to ANZ clinics, but as a manufacturer rather than distributor.
- L'Oréal Dermatological Beauty: Owner of SkinCeuticals, La Roche-Posay, Vichy, and CeraVe. Competes in the medical-grade skincare category Dermocosmètica distributes, though primarily via pharmacy/retail rather than clinic-only channels.
Direct peers
- Cryomed Aesthetics: ANZ distributor of medical aesthetic devices, injectables, and consumables to clinics and medi-spas. Closely comparable in business model (specialty distribution into the appearance-medicine channel) and customer base.
- Aesthetic Beauty Group International (ABGI): Australian-owned group distributing aesthetic and skincare brands into ANZ medical and beauty channels. Comparable as a multi-brand specialty aesthetics distributor serving clinics and salons.
- Advanced Skin Technology: Australian specialty distributor of premium cosmeceutical and medical-grade skincare brands (including SkinCeuticals) to medical and aesthetic clinics. Most directly comparable ANZ pure-play dermocosmetic distributor with overlapping clinic-channel GTM.
- High Tech Medical: ANZ distributor of medical aesthetic devices, cosmeceuticals, and professional skincare. Comparable in channel (clinics), geography (ANZ), and product mix (medical-grade skincare and aesthetics).
Others
- Eneomey (Laboratoire ENEOMEY): French dermo-cosmetic brand that Dermocosmètica exclusively distributes in ANZ. Included as a partner/upstream supplier rather than competitor, illustrating the model of Dermocosmètica's brand portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Dermocosmètica social profiles
Digital presenceDermocosmètica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dermocosmètica leadership team
Management profileNumber of profiles
Profiles1 record
Dermocosmètica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dermocosmètica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dermocosmètica
What does Dermocosmètica do?
Dermocosmètica distributes premium, science-backed dermocosmetic products — including cosmeceuticals, professional peels, therapeutic skincare, and injectables — from 11 global brand partners (Dermaceutic, Biopelle, Isdinceutics, Emepelle, Cantabria Labs' Biretix and Neoretin, IBSA Derma, Eneomey, Prescribed Solutions DNA, OC Eight, and LMX4) exclusively to authorised medical clinics, pharmacies, and hospitals across Australia and New Zealand. The company does not sell direct to consumers; revenue is generated through wholesale orders placed by over 1,500 stockists, supported by territory-based Business Development Managers, clinical training programs, and KOL-led education.
Is Dermocosmètica a public or private company?
Dermocosmètica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dermocosmètica founded?
Dermocosmètica was founded in 2011. It employs 11 to 50 people.
Where is Dermocosmètica based?
Dermocosmètica is headquartered in Coburg, Australia, in the Oceania region.
How does Dermocosmètica make money?
One revenue line is on record: wholesale / B2B Distribution.
Who are Dermocosmètica's main competitors?
Broad incumbents on record are AbbVie (Allergan Aesthetics), Sinclair Pharma, Galderma, Croma-Pharma and L'Oréal Dermatological Beauty. Direct peers are Cryomed Aesthetics, Aesthetic Beauty Group International (ABGI), Advanced Skin Technology and High Tech Medical. Eneomey (Laboratoire ENEOMEY) is listed as an others.
Does Dermocosmètica have an API?
No public API is recorded for Dermocosmètica.
What industry is Dermocosmètica in?
Dermocosmètica's product category is Medical-grade dermocosmetic distribution. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 424210 and its SIC code is 5122.